Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down1.35% Nasdaq Down1.12%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NCM

5.21 Up 0.10(1.96%) 4:00PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Net Income (43,951) (20,141) (24,587)
Operating Activities, Cash Flows Provided By or Used In
Depreciation431  112  150  
Adjustments To Net Income10,140  (4,279)4,369  
Changes In Accounts Receivables -   -   -  
Changes In Liabilities22,836  1,815  1,347  
Changes In Inventories -   -   -  
Changes In Other Operating Activities(98)(343)(659)
Total Cash Flow From Operating Activities (10,642) (22,836) (19,380)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures -  (15)(64)
Investments(21,382)4,159  (39,124)
Other Cash flows from Investing Activities11  34  104  
Total Cash Flows From Investing Activities (21,371) 4,178   (39,084)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock22,660  4,121  68,428  
Net Borrowings14,982  9,625   -  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 37,642   13,746   68,428  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 5,629   (4,912) 9,964  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.